4 recap points by Dr. Arnas Karužas on European Society of Cardiology Congress in London:
1) There is exponential growth in trials with AI. Importantly, these innovations are being implemented into daily practice.
2) New guidelines for atrial fibrillation management were introduced. They offer a fresh approach to evaluating thromboembolism risk. The CHA2DS2VASc score no longer includes sex. The new recommendation is to use the CHA2DS2 VA score.
3) For atrial fibrillation lasting more than 24 hours, specific protocols are advised. Three weeks of oral anticoagulation or a transesophageal echocardiogram is recommended before cardioversion.
4) guidelines have been updated. They now provide a new estimation of risk factor-weighted clinical likelihood for obstructive CAD. This change addresses the previous overestimation issues with obstructive CAD.
Echocardiography software is part of the bigger AI transformation in cardiology. Ligence is proud to be shaping medical history.
